The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
The need for personalised medicine for rheumatoid arthritis
Cardiovascular disease in rheumatoid arthritis
Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
Bosentan treatment of digital ulcers related to systemic sclerosis
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis
Ankylosing Spondylitis Disease Activity Score (ASDAS)
An assessment of disease flare in patients with systemic lupus erythematosus
Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review
Clinical and radiographic disease course of hand osteoarthritis and determinants of outcome after 6 years
Subregional effects of meniscal tears on cartilage loss over 2 years in knee osteoarthritis
Measurement of damage in systemic vasculitis
Pulmonary outcome in juvenile dermatomyositis
Development of a simple prognostic nomogram for individualising 5-year and 10-year absolute risks of fracture
Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients
Skin thickness progression rate
Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis
The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype
A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis
The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia
Changes in hip fracture rate before and after total knee replacement due to osteoarthritis
Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis
Vitamin D
Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients
Effectiveness of switching between TNF inhibitors in ankylosing spondylitis
Meta-analyses of genes modulating intracellular T3 bio-availability reveal a possible role for the DIO3 gene in osteoarthritis susceptibility
A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis
Prediction of MRI erosive progression
Nailfold capillaroscopy for day-to-day clinical use
Effect of intra-articular corticosteroid injections and inflammation on periarticular and generalised bone loss in early rheumatoid arthritis
Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities
Elevated serum interleukin-27 levels in patients with systemic sclerosis
Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus
GDF5 deficiency in mice is associated with instability-driven joint damage, gait and subchondral bone changes
Endogenous regeneration after collagenase-induced knee joint damage in the adult newt Notophthalmus viridescens
Prostaglandin EP2 receptor signalling inhibits the expression of matrix metalloproteinase 13 in human osteoarthritic chondrocytes
Elevated number of recently activated T cells in bone marrow of patients with rheumatoid arthritis
Anti-Golgi autoantibodies are not clinically associated with systemic autoimmune diseases
Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjögren's syndrome